OSA's Digital Library

Biomedical Optics Express

Biomedical Optics Express

  • Editor: Joseph A. Izatt
  • Vol. 4, Iss. 6 — Jun. 1, 2013
  • pp: 900–908

Characterization and treatment monitoring of inflammatory arthritis by photoacoustic imaging: a study on adjuvant-induced arthritis rat model

Justin R. Rajian, Xia Shao, David L. Chamberland, and Xueding Wang  »View Author Affiliations


Biomedical Optics Express, Vol. 4, Issue 6, pp. 900-908 (2013)
http://dx.doi.org/10.1364/BOE.4.000900


View Full Text Article

Enhanced HTML    Acrobat PDF (3775 KB)





Browse Journals / Lookup Meetings

Browse by Journal and Year


   


Lookup Conference Papers

Close Browse Journals / Lookup Meetings

Article Tools

Share
Citations

Abstract

Neovascularity also known as angiogenesis is an early feature of inflammatory arthritis disease. Therefore, identifying the development of neovascularity is one way to potentially detect and characterize arthritis. Laser-based photoacoustic imaging (PAI) is an emerging biomedical imaging modality which may aid in the detection of both early and continued development of neovascularity. In this work, we investigated the feasibility of PAI to measure angiogenesis, for the purpose of evaluating and monitoring inflammatory arthritis and responses to treatment. The imaging results on an arthritis rat model demonstrate that 1) there is noticeable enhancement in image intensities in the arthritic ankle joints when compared to the normal joints, and 2) there is noticeable decrease in image intensities in the arthritic ankle joints after treatment when compared to the untreated arthritic joints. In order to validate the findings from PAI, we performed positron emission tomography (PET) and histology on the same joints. The diameters of the ankle joints, as a clinical score of the arthritis, were also measured at each time point.

© 2013 OSA

OCIS Codes
(110.7170) Imaging systems : Ultrasound
(170.5120) Medical optics and biotechnology : Photoacoustic imaging

ToC Category:
Photoacoustic Imaging and Spectroscopy

History
Original Manuscript: March 4, 2013
Revised Manuscript: April 22, 2013
Manuscript Accepted: May 7, 2013
Published: May 17, 2013

Citation
Justin R. Rajian, Xia Shao, David L. Chamberland, and Xueding Wang, "Characterization and treatment monitoring of inflammatory arthritis by photoacoustic imaging: a study on adjuvant-induced arthritis rat model," Biomed. Opt. Express 4, 900-908 (2013)
http://www.opticsinfobase.org/boe/abstract.cfm?URI=boe-4-6-900


Sort:  Author  |  Year  |  Journal  |  Reset  

References

  1. Centers for Disease Control and Prevention (CDC), “Racial/ethnic differences in the prevalence and impact of doctor-diagnosed arthritis—United States, 2002,” MMWR Morb. Mortal. Wkly. Rep.54(5), 119–123 (2005). [PubMed]
  2. O. Fitzgerald and B. Bresnihan, “Synovial vascularity is increased in rheumatoid arthritis: comment on the article by Stevens et al,” Arthritis Rheum.35(12), 1540–1541 (1992). [CrossRef] [PubMed]
  3. A. E. Koch, “Review: angiogenesis: implications for rheumatoid arthritis,” Arthritis Rheum.41(6), 951–962 (1998). [CrossRef] [PubMed]
  4. A. J. Hayes, “Angioneogenesis in rheumatoid arthritis,” Lancet354(9176), 423–424 (1999). [CrossRef] [PubMed]
  5. E. M. Paleolog and J. M. Miotla, “Angiogenesis in arthritis: role in disease pathogenesis and as a potential therapeutic target,” Angiogenesis2(4), 295–307 (1998). [CrossRef] [PubMed]
  6. D. A. Walsh, “Angiogenesis and arthritis,” Rheumatology (Oxford)38(2), 103–112 (1999). [CrossRef] [PubMed]
  7. A. E. Koch, “Angiogenesis as a target in rheumatoid arthritis,” Ann. Rheum. Dis.62(90002Suppl 2), ii60–ii67 (2003). [CrossRef] [PubMed]
  8. P. H. Wooley, “Animal models of rheumatoid arthritis,” Curr. Opin. Rheumatol.3(3), 407–420 (1991). [CrossRef] [PubMed]
  9. M. M. Halloran, J. M. Woods, R. M. Strieter, Z. Szekanecz, M. V. Volin, S. Hosaka, G. K. Haines, S. L. Kunkel, M. D. Burdick, A. Walz, and A. E. Koch, “The role of an epithelial neutrophil-activating peptide-78-like protein in rat adjuvant-induced arthritis,” J. Immunol.162(12), 7492–7500 (1999). [PubMed]
  10. S. Shahrara, A. E. I. Proudfoot, J. M. Woods, J. H. Ruth, M. A. Amin, C. C. Park, C. S. Haas, R. M. Pope, G. K. Haines, Y. Y. Zha, and A. E. Koch, “Amelioration of rat adjuvant-induced arthritis by Met-RANTES,” Arthritis Rheum.52(6), 1907–1919 (2005). [CrossRef] [PubMed]
  11. M. M. Halloran, Z. Szekanecz, N. Barquin, G. K. Haines, and A. E. Koch, “Cellular adhesion molecules in rat adjuvant arthritis,” Arthritis Rheum.39(5), 810–819 (1996). [CrossRef] [PubMed]
  12. J. D. Taurog, D. C. Argentieri, and R. A. McReynolds, “Adjuvant arthritis,” Methods Enzymol.162, 339–355 (1988). [CrossRef] [PubMed]
  13. D. A. Barnes, J. Tse, M. Kaufhold, M. Owen, J. Hesselgesser, R. Strieter, R. Horuk, and H. D. Perez, “Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model,” J. Clin. Invest.101(12), 2910–2919 (1998). [CrossRef] [PubMed]
  14. X. Wang, J. B. Fowlkes, J. M. Cannata, C. Hu, and P. L. Carson, “Photoacoustic imaging with a commercial ultrasound system and a custom probe,” Ultrasound Med. Biol.37(3), 484–492 (2011). [CrossRef] [PubMed]
  15. M. K. Chen and T. R. Guilarte, “Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair,” Pharmacol. Ther.118(1), 1–17 (2008). [CrossRef] [PubMed]
  16. V. Papadopoulos and L. Lecanu, “Translocator protein (18 kDa) TSPO: an emerging therapeutic target in neurotrauma,” Exp. Neurol.219(1), 53–57 (2009). [CrossRef] [PubMed]

Cited By

Alert me when this paper is cited

OSA is able to provide readers links to articles that cite this paper by participating in CrossRef's Cited-By Linking service. CrossRef includes content from more than 3000 publishers and societies. In addition to listing OSA journal articles that cite this paper, citing articles from other participating publishers will also be listed.


« Previous Article  |  Next Article »

OSA is a member of CrossRef.

CrossCheck Deposited